BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

696 related articles for article (PubMed ID: 8754703)

  • 1. Antithrombotic therapy in atrial fibrillation.
    Turpie AG; Connolly SJ
    Can Fam Physician; 1996 Jul; 42():1341-5. PubMed ID: 8754703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Status of antithrombotic therapy for patients with atrial fibrillation in university hospitals.
    Albers GW; Yim JM; Belew KM; Bittar N; Hattemer CR; Phillips BG; Kemp S; Hall EA; Morton DJ; Vlasses PH
    Arch Intern Med; 1996 Nov; 156(20):2311-6. PubMed ID: 8911237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Atrial fibrillation and apoplexy--risks and prevention].
    Koefoed BG; Gulløv AL; Petersen P
    Nord Med; 1996 Jun; 111(6):171-5. PubMed ID: 8700641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Antithrombotic therapy of atrial fibrillation].
    Chalon S; Lechat P
    Arch Mal Coeur Vaiss; 1996 Nov; 89(11 Suppl):1533-42. PubMed ID: 9092415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atrial fibrillation and stroke. Three new studies, three remaining questions.
    Albers GW
    Arch Intern Med; 1994 Jul; 154(13):1443-8. PubMed ID: 8017999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Warfarin sodium or aspirin therapy to prevent stroke in nonrheumatic atrial fibrillation. Answered and unanswered questions.
    Stratton JR
    West J Med; 1995 Aug; 163(2):177-9. PubMed ID: 7571577
    [No Abstract]   [Full Text] [Related]  

  • 7. Risks and benefits of combining aspirin with anticoagulant therapy in patients with atrial fibrillation: an exploratory analysis of stroke prevention using an oral thrombin inhibitor in atrial fibrillation (SPORTIF) trials.
    Flaker GC; Gruber M; Connolly SJ; Goldman S; Chaparro S; Vahanian A; Halinen MO; Horrow J; Halperin JL;
    Am Heart J; 2006 Nov; 152(5):967-73. PubMed ID: 17070169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The efficacy of aspirin in patients with atrial fibrillation. Analysis of pooled data from 3 randomized trials. The Atrial Fibrillation Investigators.
    Arch Intern Med; 1997 Jun; 157(11):1237-40. PubMed ID: 9183235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Atrial fibrillation and thromboembolic events prevention. State of the art].
    Matteoli S; Trappolini M; Chillotti FM
    Minerva Cardioangiol; 2001 Feb; 49(1):1-13. PubMed ID: 11279381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Atrial fibrillation due to non-valvular causes: indications for antithrombotic therapy].
    Codinach Huix P
    Med Clin (Barc); 1996 Apr; 106(15):586-9. PubMed ID: 8656759
    [No Abstract]   [Full Text] [Related]  

  • 11. Preventing stroke in patients with atrial fibrillation.
    Edds W; Newton W
    J Fam Pract; 2000 Jan; 49(1):8-9. PubMed ID: 10678330
    [No Abstract]   [Full Text] [Related]  

  • 12. A randomised controlled trial of warfarin versus aspirin for stroke prevention in octogenarians with atrial fibrillation (WASPO).
    Rash A; Downes T; Portner R; Yeo WW; Morgan N; Channer KS
    Age Ageing; 2007 Mar; 36(2):151-6. PubMed ID: 17175564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physicians' attitudes toward oral anticoagulants and antiplatelet agents for stroke prevention in elderly patients with atrial fibrillation.
    Kutner M; Nixon G; Silverstone F
    Arch Intern Med; 1991 Oct; 151(10):1950-3. PubMed ID: 1929682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of thromboembolic events in atrial fibrillation.
    Koefoed BG; Gulløv AL; Petersen P
    Thromb Haemost; 1997 Jul; 78(1):377-81. PubMed ID: 9198182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anticoagulant prophylaxis against stroke in atrial fibrillation: effectiveness in actual practice.
    Caro JJ; Flegel KM; Orejuela ME; Kelley HE; Speckman JL; Migliaccio-Walle K
    CMAJ; 1999 Sep; 161(5):493-7. PubMed ID: 10497604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Warfarin, aspirin, and atrial fibrillation.
    Harv Heart Lett; 1998 Aug; 8(12):4-6. PubMed ID: 9713234
    [No Abstract]   [Full Text] [Related]  

  • 17. Primary prevention of stroke.
    Martinez-Riera A; Santolaria-Fernandez F; Gonzalez-Reimers E
    N Engl J Med; 1996 Apr; 334(17):1138; author reply 1139. PubMed ID: 8598884
    [No Abstract]   [Full Text] [Related]  

  • 18. Antithrombotic treatment in atrial fibrillation.
    Lip GY; Boos CJ
    Postgrad Med J; 2008 May; 84(991):252-8. PubMed ID: 18508982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Warfarin for atrial fibrillation. The patient's perspective.
    Man-Son-Hing M; Laupacis A; O'Connor A; Wells G; Lemelin J; Wood W; Dermer M
    Arch Intern Med; 1996 Sep; 156(16):1841-8. PubMed ID: 8790079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Should hemodialysis patients with atrial fibrillation undergo systemic anticoagulation? A cost-utility analysis.
    Quinn RR; Naimark DM; Oliver MJ; Bayoumi AM
    Am J Kidney Dis; 2007 Sep; 50(3):421-32. PubMed ID: 17720521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.